Eureka Therapeutics, Inc., a clinical-stage biotechnology company pioneering safer and more effective T-cell therapies, today announced the appointment of Samuel So, MBBS, FACS, a globally recognized ...

(Web Desk) - Consuming moldy food, drinking alcohol, and reusing fried oil can place undue stress on the liver’s detoxification process, potentially increasing the risk of liver cancer over time.

Discover how lymphoid structures and germinal centers provide powerful prognostic insights into colorectal cancer.

A Lancet study projects a surge in liver cancer cases, reaching 1.52 million by 2050, primarily driven by obesity. Deaths are ...

Adam Wereszczynski was gobsmacked when tests revealed he had liver disease -he now wants to warn others about the dangers of ...

Precision BioSciences Inc., a clinical-stage company developing gene editing therapies for diseases with high unmet need, has ...

First clinical trial launches for a therapeutic vaccine targeting chronic hepatitis B, aiming to boost immune response and ...

This“Spark and Fan” treatment strategy could potentially offer a simple and well tolerated solution for a wide range of future HBV functional cur ...

Allogene Therapeutics has reported a patient death tied to its anti-CD52 monoclonal antibody used for lymphodepletion in its ...

In July 2025, Pfizer announced a study to establish baseline prospective efficacy data of current FIX prophylaxis replacement ...

CAMBRIDGE, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- ® (Fulcrum) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with ...

ZUG, Switzerland and BOSTON, Aug. 04, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...